NCT03626441

Brief Summary

This study evaluates the effectiveness of ginger on the incidence of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Half the patients were given an oral dose of ginger preoperatively and half received placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Dec 2017

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 12, 2018

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 14, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 13, 2018

Completed
Last Updated

August 13, 2018

Status Verified

August 1, 2018

Enrollment Period

6 months

First QC Date

July 14, 2018

Last Update Submit

August 7, 2018

Conditions

Keywords

Postoperative Nausea and VomitingGinger

Outcome Measures

Primary Outcomes (1)

  • Incidence of post operative nausea or vomiting

    The proportion of patient who have any episodes of nausea or vomiting following surgery

    12 hours after surgery

Secondary Outcomes (7)

  • Severity of post operative Nausea and vomiting

    12 hours after surgery

  • Severity of post operative Nausea and vomiting

    24 hours after surgery

  • Severity of post operative Nausea and vomiting

    48 hours after surgery

  • Severity of post operative Nausea and vomiting

    12 hours after surgery

  • Severity of post operative Nausea and vomiting

    24 hours after surgery

  • +2 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.

Dietary Supplement: Placebo

Ginger

EXPERIMENTAL

Two coloured capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger, given 2 hours before the scheduled start of surgery.

Dietary Supplement: GingerDietary Supplement: Placebo

Interventions

GingerDIETARY_SUPPLEMENT

Capsules containing 0.5g ginger powder, flavoured with non-active essence of ginger

Ginger
PlaceboDIETARY_SUPPLEMENT

Two coloured capsules containing 0.5 mg of cornstarch and flavoured with non-active essence of ginger.

GingerPlacebo

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or above
  • Undergoing elective intra-abdominal, gynaecological surgery

You may not qualify if:

  • Allergy to ginger, ginger by-products or cornstarch
  • Gastroesophageal reflux disease (GERD)
  • Allergy to any of the Anaesthesia Agents
  • Inability to swallow capsules.
  • psychiatric illness which prevents patients giving informed consent.
  • Psychological which prevents patients giving informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of the West Indies

Kingston, Kng 7, 00000, Jamaica

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

ginger extract

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • Hyacinth Harding, DM

    UWI, Faculty of medical sciencces

    PRINCIPAL INVESTIGATOR
  • Andrea Myers, MD

    UWI, Faculty of medical sciencces

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Sequentially numbered, sealed, opaque envelopes prepared and opened the evening before the surgery. Tablets containing either placebo or ginger allocated by a person not involved in any other aspect of the study and administered on the morning of surgery.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Quadruple, blind randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate lecturer

Study Record Dates

First Submitted

July 14, 2018

First Posted

August 13, 2018

Study Start

December 2, 2017

Primary Completion

June 12, 2018

Study Completion

June 14, 2018

Last Updated

August 13, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

There is no plan to make patient data available to other researchers

Locations